PINK1 and Parkin:emerging themes in mitochondrial homeostasis by McWilliams, Thomas G. & Muqit, Miratul M. K.
                                                              
University of Dundee
PINK1 and Parkin
McWilliams, Thomas G.; Muqit, Miratul M. K.
Published in:
Current Opinion in Cell Biology
DOI:
10.1016/j.ceb.2017.03.013
Publication date:
2017
Document Version
Final published version
Link to publication in Discovery Research Portal
Citation for published version (APA):
McWilliams, T. G., & Muqit, M. M. K. (2017). PINK1 and Parkin: emerging themes in mitochondrial homeostasis.
Current Opinion in Cell Biology, 45, 83-91. DOI: 10.1016/j.ceb.2017.03.013
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 01. Jul. 2017
PINK1 and Parkin: emerging themes in mitochondrial
homeostasis
Thomas G McWilliams1 and Miratul MK Muqit1,2
The Parkinson’s disease (PD)-associated protein kinase,
PTEN-induced putative kinase1 (PINK1), and ubiquitin E3
ligase, Parkin function in a common signalling pathway known
to regulate mitochondrial network homeostasis and quality
control, including mitophagy. The multistep activation of this
pathway, as well as an unexpected convergence between the
post-translational modifications of ubiquitylation and
phosphorylation, has added breadth to our understanding of
cellular damage responses during human disease. In concert
with these new insights in signal transduction, unique
modalities and signatures of vertebrate mitophagy have been
unravelled in vivo for the very first time. The cell biology of
mammalian mitophagy, and the roles of PINK1-Parkin
signalling in vivo have emerged to be more complex than
previously thought.
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Introduction: an evolving view of
mitochondrial homeostasis
Whilst mitochondria may have granted eukaryotes the
ultimate survival advantage during evolution, the dys-
function of these dynamic and functionally pleiotropic
organelles confers a potentially devastating vulnerability
to mammalian cells. This is particularly relevant in the
context of terminally differentiated or long-lived cells
such as neurons, cardiomyocytes and renal tubular cells.
Complex pathways have evolved to sense, label and
sequester damaged or dysfunctional mitochondria to
neutralise their cytotoxic potential. One such mecha-
nism is the delivery of compromised mitochondria or
associated mitochondrial components to the lysosome
for elimination, via the autophagy pathway [1].
Mitochondrial autophagy or ‘mitophagy’ is receiving
increased attention as a major pathway that sustains
mitochondrial network homeostasis, by regulating mito-
chondrial number and protecting cells from the delete-
rious effects of ‘mitotoxicity’. Mutations in human
PTEN-induced kinase 1 (PINK1) and the RING-
IBR-RING (RBR) E3-ubiquitin ligase Parkin (encoded
by PARK6 and PARK2 genes, respectively) result in
early-onset Parkinson’s disease (PD) (Figure 1) [2].
Initial discoveries in Drosophila melanogaster revealed
both of these proteins function within a common, evo-
lutionarily conserved mitochondrial homeostasis path-
way. Landmark cell-based studies demonstrated that
PINK1-Parkin signalling regulates stimulus-induced
mitochondrial clearance in vitro, and research on the
molecular regulation of this and related responses has
proliferated dramatically over the past decade. Whilst
the ‘PINK1-Parkin axis’ has received the great majority
of attention, it is important to note that PINK1-Parkin-
independent mitophagy is emerging as a burgeoning
area of research. Reciprocally, mitophagy-independent
functions of PINK1/Parkin are also widely observed.
Recent breakthroughs have redefined our view of verte-
brate mitophagy in vivo, and provoke a reassessment in
our understanding of how mitochondrial quality control
is regulated in a variety of contexts.
PINK1, phospho-ubiquitin (p-Ub), Parkin and
the regulation of stimulus-induced mitophagy
Groundbreaking work by the Youle laboratory initially
linked Parkin to mitophagy, and subsequent contribu-
tions from many other laboratories have defined a central
role for PINK1 in regulating Parkin following mitochon-
drial damage. Under steady state conditions, PINK1 is
constitutively imported into mitochondria, cleaved and
degraded via the N-end rule pathway. The proteolysis of
PINK1 is mediated by the inner mitochondrial mem-
brane associated PARL protease, and regulated by the
recently described SPY complex [3]. Upon the loss of
mitochondrial membrane potential that can be induced
artificially by mitochondrial uncouplers (e.g. carbonyl
cyanide m-chlorophenyl hydrazine (CCCP)), PINK1
becomes stabilised and activated on the outer mitochon-
drial membrane (OMM) by mechanisms that are not yet
fully elaborated [4,5]. Drosophila studies suggest PINK1
levels on ‘healthy mitochondria’ are regulated by the
LON protease, however evidence for this in mammalian
cells remains unclear [6]. Cytosolic Parkin is recruited to
damaged mitochondria where it becomes activated [5,7].
Both Parkin translocation and its E3-ligase activity are
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dependent upon the enzymatic activity of PINK1. Over
the past two years, the multistep mechanistic regulation
of Parkin activation has been elaborated in great detail
(Figure 2) [5].
Parkin exists in a native autoinhibited conformation [8].
Upon mitochondrial depolarisation, activated PINK1
phosphorylates both Ubiquitin and Parkin at their respec-
tive Ser65 residues [7,9,10,11,12,]. Detailed struc-
tural and biophysical characterisation by independent
laboratories demonstrated that phospho-ubiquitin (p-
Ub) binds with high affinity to phosphorylated Parkin
to allosterically induce conformational changes that pro-
mote recruitment of its cognate charged E2, and stimula-
tion of Parkin activity [13–17]. Active Parkin is reported
to ubiquitylate myriad putative substrates that reside in
the OMM, by elongating pre-existing ubiquitin chains
attached to OMM proteins or ubiquitylating substrates de
novo. Whilst the role of p-Ub as an allosteric activator is
evident, whether p-Ub may play other physiological roles
is unclear. It has been reported that poly-p-Ub chains are
more resistant to proteolysis by several deubiquitinases,
suggesting that p-Ub may act as an important signal to
maintain Parkin-directed ubiquitylation [12]. Given the
pleiotropy of substrates, it is also possible that p-Ub may
function as a semaphore to direct or guide Parkin to
selected substrates. In this regard, it will prove exciting
to determine if other proteins contain similar p-Ub bind-
ing pockets akin to that found on Parkin [5,18]. A leading
hypothesis suggests particular combinations of poly-p-Ub
chain topologies may represent a distinct molecular code
required for the selective recruitment of autophagy
machinery. Quantitative proteomics revealed damaged
mitochondria become decorated with a diverse array of
polyubiquitin linkages (Lys 6, 11, 48, 63) [7]. These
OMM-polyubiquitin chains serve as substrates for PINK1
phosphorylation and adaptors for Parkin, resulting in a
‘feed-forward’ amplification loop that drives the clearance
of the damaged organelle and ultimately, the completion
of mitophagy (Figure 2) [7,19,20].
The recruitment of ubiquitin-binding autophagy receptor
proteins is necessary for local phagophore formation at
damaged mitochondria and, to date six such receptors
have been identified: NBR1, NDP52, OPTN, p62/
SQSTM1, TAX1BP1 and TOLLIP [5]. Converging stud-
ies using clustered regularly interspaced short palin-
dromic repeats/CRISPR-associated protein 9 (CRISPR/
Cas9) genome editing suggest NDP52/OPTN are essen-
tial for PINK1-Parkin-dependent mitophagy, and
TAX1BP1 to a lesser extent [21,22]. Furthermore,
TBK1 phosphorylation of these receptors enhances inter-
actions between LC3 and ubiquitin [22,23]. Interest-
ingly, PINK1 may also generate p-Ub and recruit NDP52/
OPTN independently of Parkin to drive low-level mito-
phagy, implying the involvement of additional ubiquitin
E3 ligases [21]. Until recently, it was widely assumed
that the ATG-conjugation machinery is crucial for
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Domain architecture of PINK1 and Parkin.
Schematic depicting the major regions of the mitochondrial-associated kinase PINK1, and the RBR-E3 Ubiquitin Ligase Parkin. Selected human
disease mutations are shown in black, key phospho-sites in red and regulatory residues in green. MTS: mitochondrial targeting sequence, TM:
transmembrane domain, INS: insertion, CTD: C-terminal domain, UBL: ubiquitin-like domain, RING: really interesting new gene domain, BRcat:
benign-catalytic domain, Rep: repressor element, Rcat: required for catalysis domain.
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autophagosome biogenesis and cargo incorporation. A
new study has cast doubt on this, suggesting that while
LC3 is essential for autophagosome-endolysosome
fusion, it is dispensable for the autophagic encapsulation
of damaged mitochondria [24]. Consistent with a role
outside of autophagosome biogenesis, other recent obser-
vations indicate LC3 conjugation is instead required to
orchestrate the degradation of the inner autolysosomal
membrane following autophagosome-lysosome fusion
[25].
It has recently been reported that the mitochondrial
ubiquitin ligase 1 (MUL1; also known as MULAN and
MAPL) functions with Parkin to regulate degradation of
paternal mitochondria from sperm, but the mechanism by
which MUL1 induces mitophagy is unknown [26]. Rab
GTPase proteins have also been implicated in mitophagy,
and two RAB-GAPs (TBC1D15 and TBC1D17) modu-
late the activity of Rab7 to regulate encapsulation of
damaged mitochondria by the autophagosome [27].
Recently published phosphoproteomic analyses demon-
strated that Rab8A, 8B and 13 are indirect substrates of
PINK1 [28]. The temporal dynamics of Rab phosphor-
ylation following mitochondrial insult is consistent with
their potential contribution to the later stages of mito-
phagy [28]. The links between PINK1, TBK1 and
Optineurin signalling are intriguing, given previous
reports that Optineurin is an effector protein of Rab8A,
suggesting a potential nexus. Given the function of
NDP52/OPTN/TBK1/Rab7 in xenophagy and the
ancient origins of mitochondria from a-proteobacteria,
interesting parallels have also been drawn between mito-
phagy and xenophagy [5,29].
The idea that dysregulated PINK1-Parkin signalling
leads to impaired mitophagy is an attractive hypothesis,
however there has been no clear validation of this mech-
anism in the aetiology of PD. Although PINK1-Parkin
mediated mitophagy is highly reproducible in vitro, it is
difficult to reconcile the actual contribution of PINK1-
Parkin signalling to mitochondrial homeostasis in vivo
due to some potentially confounding factors. (1) The
majority of studies utilise proliferating cell lines and
although such systems are unrivalled for the tractable
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PINK1, p-Ub, Parkin and mitophagy.
The molecular regulation of depolarisation-induced mitochondrial clearance is well established. PINK1-Parkin-dependent signalling triggers cycles
of ubiquitylation on the OMM, which result in the recruitment of the autophagy machinery, autophagosome formation and eventual clearance of
the damaged organelle. Times are approximate and refer to observations from in vitro studies. PINK1 can also drive low-level mitophagy,
independently of Parkin.
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molecular dissection of signalling pathways in vitro, they
relate poorly to the post-mitotic and complex A9 mesen-
cephalic dopaminergic (mesDA) nigrostriatal projection
neurons that selectively degenerate in PD. (2) High levels
of PINK1/Parkin expression are usually required to
detect a robust induction of mitophagy (4). It is difficult
to relate the cytotoxic induction stimuli (e.g. CCCP) to an
analogous physiological correlate that evokes a similar
level of mitochondrial clearance in vivo. Additionally,
genetic ablation of germ-line Pink1 or Parkin in mice
does not recapitulate the overt neuropathology or motor
dysfunction that manifests in PD.
However, a recent proof-of-concept study has highlighted
the importance of endogenous Parkin in mediating neural
mitochondrial homeostasis in vivo [30]. To simulate
conditions of mitochondrial stress in the absence of
endogenous Parkin and investigate the effect of this on
nigrostriatal pathway integrity, the authors crossed Par-
kin-deficient mice with mitochondrial PolgD257A ‘mutator’
mice. The well-characterised mutator model accumulates
mitochondrial DNA mutations because of defective mito-
chondrial proofreading by polymerase g. Although indi-
vidual mutants (Parkin-deficient or PolgD257A mice) alone
did not exhibit gross dopamine/dopaminergic (DA) neu-
ropathology or behavioural abnormalities, double-mutant
animals with loss of Parkin under conditions of constitu-
tive mitochondrial stress in vivo exhibited age-dependent
DA neuron loss and levodopa-responsive motor dysfunc-
tion [30]. Whilst this important study demonstrated the
requirement of Parkin for DA neuronal homeostasis
under conditions of mitochondrial stress in vivo, it
remains unclear if this pathology is a consequence of
dysregulated mitophagy in double-mutant mice. Never-
theless, this important in vivo finding demonstrates the
contribution of endogenous Parkin to mesDA neural
integrity under conditions of stress in
vivo. Interestingly and unlike Pink1 knockout (KO) mice,
a recently generated Pink1 KO rat model exhibits loco-
motor dysfunction and age-related DA cell loss, in addi-
tion to altered neural metabolomics [31,32]. In contrast,
Parkin KO rats do not exhibit significant PD-related
pathology due to probable redundancy of E3 ubiquitin
ligases, for example MUL1 [26].
Fiesel and Springer provided intriguing evidence for the
physiological relevance of canonical PINK1-Parkin sig-
nalling in humans by demonstrating the age-dependent
accumulation of p-Ub in post-mortem brains, and its
reciprocal absence in SNpc sections from a patient with
a compound heterozygous PARK6 mutation [33].
Although studies in cultured cells and post-mortem
human brain suggest PINK1 to be the ubiquitin kinase
for Ser65-Ub, this does not preclude a role for other
protein kinases that may generate p-Ub in vivo, as ubi-
quitin can be phosphorylated at several other sites.
Recent advances in cell reprogramming enabled Chung
et al. to recapitulate the molecular pathophysiology of PD
in vitro using induced pluripotent stem cell (iPSC)-
derived DA neurons from PINK1/Parkin-patients [34].
Reprogrammed patient neurons exhibited aberrant mito-
chondrial morphology as well as a propensity to accumu-
late a-synuclein [34]. Importantly, this study also dem-
onstrated the influence of culture conditions on
modelling molecular pathophysiology in vitro, however
the contribution of impaired mitochondrial turnover to
the observed pathology remains unclear.
Alternate signals: PINK1 and PARKIN-
independent mitophagy
Because of their striking roles in mediating stimulus-
induced mitochondrial clearance in vitro, PINK1 and
Parkin tend to reap the limelight in most mitophagy-
related discussions. However, it should be noted that
PINK1-p-Ub-Parkin-independent mechanisms of mito-
phagy exist and these constitute an equally exciting and
emerging area of research. These could also be viewed as
ubiquitin-dependent and ubiquitin-independent mecha-
nisms of selective autophagy, reviewed in Ref. [35]. The
first such mechanism described was NIX-dependent
mitophagy (originally reported by the Ney laboratory
and shown to be an ATG8 receptor by Dikic and collea-
gues) [1]. NIX and the closely related BNIP3 are induced
by hypoxia, trigger autophagy and have apoptotic-related
functions. They both localise to the OMM and contain
LC3-interation motifs (LIR; WXXLL), thus acting as
autophagy receptors. Upon activation, BNIP3 and NIX
prompt opening of the mitochondrial permeability tran-
sition pore (mPTP), depolarisation and recruitment of
LC3/GABARAPs for autophagosome formation. NIX has
been shown to be important for mitochondrial elimination
during developmental erythrocyte maturation. Cross talk
between NIX/BNIP3 and PINK1-Parkin mitophagy
pathways is unclear, although NIX has been implicated
in the mitochondrial translocation of Parkin.
The OMM-protein FUNDC1 (Fun14 Domain Contain-
ing 1) has also been implicated as a receptor in hypoxia-
induced mitophagy. The affinity of FUNDC1 with LC3
is controlled by Src-mediated phosphorylation of Tyr18
within its N-terminal LIR. Under hypoxia, de-phosphor-
ylation of Tyr18 enhances the FUNDC1-LC3 interaction
and evokes mitophagy. The Ser-Thr protein kinase
ULK1 has been reported to phosphorylate FUNDC1
to regulate mitophagy [1].
Iron chelation via deferiprone has also been shown to
induce mitophagy in a PINK1-Parkin-independent man-
ner. This is particularly intriguing, as dysregulated iron
metabolism has been linked to neurodegenerative dis-
ease and clinical trials with deferiprone and PD are
currently underway. It should be noted that the signalling
pathway regulating deferiprone-induced mitophagy
remains to be elucidated and it will be interesting to test
86 Cell regulation
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the contribution of other ubiquitin E3 ligases, such as the
recently described MUL1 E3 ligase [26]. Similarly ubi-
quitin can be phosphorylated at several other sites and
their relevance to mitophagy and the identity of the
upstream kinases regulating these residues remains
unknown [36].
Orchestrating mitochondrial quality control in
vivo
A major challenge in the field has been to accurately and
faithfully measure mitophagy in vivo. The inability to
measure this process in mammalian tissues has provoked
great suspense surrounding the bona fide contribution of
PINK1-pUB-Parkin signalling to mitochondrial turnover
in vivo.
Powerful insights into eukaryotic mitophagy have been
obtained from budding yeast, from the initial in vivo
studies by the Lemasters laboratory to more recent work
on p-Ub signalling. Intriguingly, although there is no
known PINK1 orthologue in yeast, Swaney et al. observed
the presence of Ser65-p-Ub in S. cerevisiae upon exposure
to oxidative stress [37]. This raises the exciting possibility
that an alternate, PINK1-like ubiquitin kinase may exist.
Invertebrate in vivo mitophagy has also been investigated
in novel reporter assays using C. elegans, where Pink1 and
Parkin were reported to orchestrate ageing-associated
mitophagy [38]. However, these studies relied upon
induction stimuli, as the basal rate of turnover in nema-
todes appears low. Fly genetics has also provided impor-
tant insights into the regulation of mitochondrial homeo-
stasis by PINK1 and Parkin [39].
In terms of mammalian mitophagy in vivo, tool develop-
ment has been integral to the field and a combination of
mouse genetics with fluorescent-reporter proteins has
culminated in the recent rise of mitophagy reporter
mouse models [40]. The recently reported mito-QC
and mt-Keima mouse models generated by the Ganley
and Finkel laboratories have unearthed the dramatic,
striking and heterogeneous nature of basal mitophagy
in vivo [41,42]. Although these models operate on a
similar pH-based principle, the Keima protein is incom-
patible with tissue fixation and users are limited to
making regional inferences about mitophagy in
vivo. Conversely, the end-point mito-QC model facilitates
the facile resolution of both mitophagy and mitochondrial
network architecture within labelled subsets of cells in
vivo at subcellular resolution. Collectively, these obser-
vations have profound implications for our view of mito-
chondrial turnover in mammals. The vast majority of our
molecular knowledge on mitophagy is derived from stud-
ies of stimulus-induced mitophagy in vitro. The hetero-
geneity of basal turnover between tissues and even
between cell types within the same organ is striking,
for example in the kidney—where mitophagy between
distal and proximal tubules is dramatically different.
Furthermore, it will be essential to determine the contri-
bution of developmental mitophagy to tissue function.
From these findings and others, it is likely that multiple
pathways regulate mitophagy in a context-dependent and
cell-specific manner.
Ultimately, it will be essential to define the contribution
of PINK1, p-Ub and Parkin to the regulation of basal
mitophagy in vertebrates by exploiting these recently
described approaches. Accurately identifying basal mito-
phagy within precise cellular subsets will be essential to
understand if dysfunctional mitophagy underpins the
selective vulnerability of particular neuronal subsets in
complex degenerative disorders such as PD. Given the
postulated contribution of dysregulated mitophagy to the
aetiology of PD, how can we reconcile such selective
pathophysiology in humans with the widespread, basal
nature of mitophagy in vivo? If PINK1/Parkin are the
master regulators of basal mitophagy, might we not
expect patients to exhibit a greater degree of extra-nigral
mitochondrial-associated pathology? These findings raise
the interesting idea that PINK1/Parkin may be required
to protect against a distinct type of stress-evoked mito-
phagy in vivo, as observed in Ref. [30]. Collectively,
these observations should stimulate an interesting debate
on the cell subtype-specific functions of PINK1/Parkin in
vivo.
Destructive and protective modalities of mitochondrial
transfer have recently been reported in neurons (Fig-
ure 3). Interestingly, depolarisation-induced axonal mito-
phagy was described in vitro in neurons with overex-
pressed Parkin [43]. The exciting phenomenon of
trans-cellular mitochondrial degradation (or axonal
trans-mitophagy) has also recently been described in vivo
within the optic nerve head [44]. Remarkably, axonal
mitochondria destined for destruction are extruded from
terminal processes, engulfed by neighbouring astrocytes
and eliminated within their lysosomes. Given the inordi-
nate complexity of the mature nervous system with 1015
connections, this topography may account for how a
spatial economy of destruction is achieved in mammalian
neurons when faced with the challenge of distance [45].
An equally intriguing discovery with implications for
mitochondrial quality control is neuro-glial mitochondrial
transfer, recently described in vitro following simulated
ischemic insult [46]. Might the acquisition of healthy
mitochondria serve to equilibrate network homeostasis,
and how is this orchestrated with basal or induced mito-
phagy during ageing? Furthermore, do these new mito-
phagy modalities rely on PINK1-Parkin signalling, and
could particular permutations of poly-p-Ub chains specify
these alternate delivery routes to the lysosome? Although
further work is required to substantiate the frequency of
such events in a variety of contexts, both discoveries have
profound implications for our understanding of nervous
system architecture at a subcellular level.
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Emerging modalities of mitochondrial quality control.
Our knowledge of mitochondrial homeostasis has expanded, and new routes to the lysosome have been uncovered. Canonical mitophagy refers
to PINK1-Parkin-dependent or independent mitophagy that has been classically studied in cultured cells. The mitochondrial-derived vesicle (MDV)
pathway is emerging as a key regulator of mitochondrial quality control. Damaged mitochondria can also be extruded from cells and degraded by
lysosomes in neighbouring cells (Transcellular mitophagy), and damaged neurons may acquire healthy mitochondria from glial cells (Neuro-glial
mitochondrial transfer). It is unclear if these latter modes of delivery are dependent on PINK1-Parkin signalling.
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Emerging themes from cell biology to
pathology
Alternate pathways have emerged where damaged mito-
chondrial components can be excised and delivered to
acidic endolysosomal compartments for degradation. In
response to oxidative stress, the McBride and Fon labo-
ratories have shown that PINK1 and Parkin mediate the
cargo-dependent export of excised mitochondrial regions
as membrane derived vesicles (MDVs) for delivery to
lysosomes [47,48]. The Qa-SNARE Syntaxin-17 was
recently implicated in this process [49]. Furthermore, a
physiological role for PINK1-Parkin signalling-depen-
dent generation of MDVs has been found in mitochon-
drial antigen presentation (MitAP) [50]. In response to
cellular stress, a novel PINK1-Parkin-mediated MDV
pathway exports mitochondrial-derived self-antigens for
presentation at the cell surface, triggering an immune
response [50]. This unexpected discovery of MitAP pro-
vides an interesting link between autoimmunity and PD
[51]. The complexity of signalling pathways regulating
the delivery of damaged mitochondria to the lysosome
also needs to be evaluated in light of emerging findings in
organelle crosstalk [52]. A variety of mitochondria-organ-
elle contact sites are emerging as key regulators of lipid
transport, mitochondrial transport and distribution [52].
Such crosstalk is also exemplified by the recent and
exciting revelation of the dual mitochondrial-ER origins
of peroxisomes [53]. The development of next-genera-
tion chemical probes for monitoring Parkin-activation
should also prove valuable in resolving the contribution
of PINK1-Parkin signalling to these new and exciting
aspects of mitochondrial cell biology [54]. Intriguing links
between mitophagy and metabolic regulation are also
emerging, especially with respect to cardiovascular devel-
opment. The Dorn laboratory demonstrated a role for
Parkin during cardiac perinatal development, by showing
that cardiomyocyte-specific ablation of Parkin at this
stage provokes a lethal cardiomyopathy caused by the
retention of foetal mitochondria. A wave of mitophagy
was observed in late embryonic mito-QC mice, suggesting
that a defined window of developmental cardiomitophagy
in utero may orchestrate an essential phase of metabolic
adaption during early life [33].
Concluding remarks
Our view of mitophagy, signal transduction and its con-
tribution to the pathophysiology of PD should be evalu-
ated in the light of mesDA neurobiology. It is estimated
that a single SN DA neuron can innervate 2.7% of the
total striatal volume, synapsing with up to 75,000 medium
spiny neurons [55,56]. Furthermore, our understanding of
DA neuron function itself is continually evolving with the
advent of more sensitive tools [57,58]. The selective
nature of mitophagy, as distinct from non-selective gen-
eral macro-autophagy cannot be understated. Although
general macroautophagy is a catabolic process that
evolved to sustain cells during instances of nutrient
deprivation, basal mitophagy proceeds in cells that have
ample access to nutrients, and represents a unique quality
control mechanism required to sustain the integrity of the
mitochondrial network. Moreover, major differences have
been unearthed with respect to the regulation of this
process in vivo. Despite major research efforts in this field,
several important questions remain unanswered (Box 1).
Ultimately, it will be imperative to combine state of the
art signalling studies with cutting edge in vivo cell biology
to clarify the precise contribution of mitophagy pathways
to mammalian neural integrity.
Funding
The research of the authors is supported by the Wellcome
Trust (101022/Z/13/Z), Medical Research Council;
Parkinson’s UK; Michael J. Fox Foundation for
Parkinson’s disease research, J Macdonald Menzies Char-
itable Trust, Biotechnology and Biological Sciences
Research Council and the EMBO YIP programme.
Acknowledgement
Due to space constraints, we were unable to provide a comprehensive
citation of all the relevant primary literature. We apologise to those whom
we have omitted. We thank Ian Ganley for critical reading of the
manuscript.
References and recommended reading
Papers of particular interest, published within the period of review,
have been highlighted as:
 of special interest
 of outstanding interest
1. Rogov V, Dotsch V, Johansen T, Kirkin V: Interactions between
autophagy receptors and ubiquitin-like proteins form the
molecular basis for selective autophagy. Mol. Cell 2014,
53:167-178.
PINK1 and Parkin: emerging themes in mitochondrial homeostasis McWilliams and Muqit 89
Box 1 Outstanding questions in the field.
 What is the precise contribution of PINK1-Parkin-mediated mito-
phagy to basal mitophagy in vivo?
 Is a chronic ‘mitotoxic’ stress required to induce PINK1-Parkin
mediated mitophagy in vivo?
 Given the prevalence of basal mitophagy in tissues, if PINK1-
Parkin mediates mitophagy in vivo—how can this be reconciled
with the highly selective degeneration observed in PD?
 What are the upstream activation stimuli of PINK1-Parkin signalling
in vivo?
 Do PINK1, p-Ub or PARKIN play a role in trans-cellular mito-
chondrial trafficking, that is during axonal trans-mitophagy or
neuroglial transfer?
 Do specific ubiquitin chain topologies or associated patterns of
these act as mitophagy-associated molecular patterns for pha-
gophore formation?
 What is the function of PINK1-Rab signalling in mitophagy?
 How are mitochondrial-organelle membrane contacts orche-
strated under conditions of acute or chronic mitochondrial stress?
 Do other ubiquitin kinases/ligases regulate mitophagy in mammals?
www.sciencedirect.com Current Opinion in Cell Biology 2017, 45:83–91
2. Bras J, Guerreiro R, Hardy J: SnapShot: genetics of Parkinson’s
disease. Cell 2015, 160 570–570 e571.
3. Wai T, Saita S, Nolte H, Muller S, Konig T, Richter-Dennerlein R,
Sprenger HG, Madrenas J, Muhlmeister M, Brandt U et al.: The
membrane scaffold SLP2 anchors a proteolytic hub in
mitochondria containing PARL and the i-AAA protease
YME1L. EMBO Rep. 2016, 17:1844-1856.
4. Pickrell AM, Youle RJ: The roles of PINK1, parkin, and
mitochondrial fidelity in Parkinson’s disease. Neuron 2015,
85:257-273.
5. Yamano K, Matsuda N, Tanaka K: The ubiquitin signal and
autophagy: an orchestrated dance leading to mitochondrial
degradation. EMBO Rep. 2016, 17:300-316.
6. Thomas RE, Andrews LA, Burman JL, Lin WY, Pallanck LJ: PINK1-
Parkin pathway activity is regulated by degradation of PINK1
in the mitochondrial matrix. PLoS Genet. 2014, 10:e1004279.
7.

Ordureau A, Sarraf SA, Duda DM, Heo JM, Jedrychowski MP,
Sviderskiy VO, Olszewski JL, Koerber JT, Xie T, Beausoleil SA
et al.: Quantitative proteomics reveal a feedforward
mechanism for mitochondrial PARKIN translocation and
ubiquitin chain synthesis. Mol. Cell 2014, 56:360-375.
By quantitative ubiquitin proteomics, this paper demonstrates the con-
tribution of feed-forward and feed-back amplification cycles of Parkin
activation by PINK1 and Phospho-ubiquitin following mitochondrial
depolarisation.
8. Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ, Shaw GS,
Walden H: Autoregulation of Parkin activity through its
ubiquitin-like domain. EMBO J. 2011, 30:2853-2867.
9.

Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA,
Banerjee S, Youle RJ: PINK1 phosphorylates ubiquitin to
activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 2014,
205:143-153.
10.

Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG,
Ritorto MS, Hofmann K, Alessi DR, Knebel A, Trost M, Muqit MM:
Parkin is activated by PINK1-dependent phosphorylation of
ubiquitin at Ser65. Biochem. J. 2014, 460:127-139.
11.

Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M,
Kimura Y, Tsuchiya H, Yoshihara H, Hirokawa T et al.: Ubiquitin is
phosphorylated by PINK1 to activate parkin. Nature 2014,
510:162-166.
These collective contributions describe the phosphorylation of ubiquitin
at Serine 65 by PINK1. Phospho-ubiquitin is essential for the full activation
of Parkin E3 ligase activity and induction of mitophagy. These papers
highlight a previously unrecognised interplay between the post-transla-
tional modifications of phosphorylation and ubiquitin.
12. Wauer T, Swatek KN, Wagstaff JL, Gladkova C, Pruneda JN,
Michel MA, Gersch M, Johnson CM, Freund SM, Komander D:
Ubiquitin Ser65 phosphorylation affects ubiquitin structure,
chain assembly and hydrolysis. EMBO J. 2015, 34:307-325.
13. Kazlauskaite A, Martinez-Torres RJ, Wilkie S, Kumar A, Peltier J,
Gonzalez A, Johnson C, Zhang J, Hope AG, Peggie M et al.:
Binding to serine 65-phosphorylated ubiquitin primes Parkin
for optimal PINK1-dependent phosphorylation and activation.
EMBO Rep. 2015, 16:939-954.
14. Kumar A, Aguirre JD, Condos TE, Martinez-Torres RJ,
Chaugule VK, Toth R, Sundaramoorthy R, Mercier P, Knebel A,
Spratt DE et al.: Disruption of the autoinhibited state primes the
E3 ligase parkin for activation and catalysis. EMBO J. 2015,
34:2506-2521.
15. Wauer T, Simicek M, Schubert A, Komander D: Mechanism of
phospho-ubiquitin-induced PARKIN activation. Nature 2015,
524:370-374.
16. Sauve V, Lilov A, Seirafi M, Vranas M, Rasool S, Kozlov G,
Sprules T, Wang J, Trempe JF, Gehring K: A Ubl/ubiquitin switch
in the activation of Parkin. EMBO J. 2015, 34:2492-2505.
17. Yamano K, Queliconi BB, Koyano F, Saeki Y, Hirokawa T,
Tanaka K, Matsuda N: Site-specific interaction mapping of
phosphorylated ubiquitin to uncover Parkin activation. J. Biol.
Chem. 2015, 290:25199-25211.
18. Durcan TM, Fon EA: The three ‘P’s of mitophagy: PARKIN,
PINK1, and post-translational modifications. Genes Dev. 2015,
29:989-999.
19. Ordureau A, Heo JM, Duda DM, Paulo JA, Olszewski JL,
Yanishevski D, Rinehart J, Schulman BA, Harper JW: Defining
roles of PARKIN and ubiquitin phosphorylation by PINK1 in
mitochondrial quality control using a ubiquitin replacement
strategy. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:6637-6642.
20. Okatsu K, Koyano F, Kimura M, Kosako H, Saeki Y, Tanaka K,
Matsuda N: Phosphorylated ubiquitin chain is the genuine
Parkin receptor. J. Cell Biol. 2015, 209:111-128.
21.

Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL,
Sideris DP, Fogel AI, Youle RJ: The ubiquitin kinase PINK1
recruits autophagy receptors to induce mitophagy. Nature
2015, 524:309-314.
22.

Heo JM, Ordureau A, Paulo JA, Rinehart J, Harper JW: The
PINK1-PARKIN mitochondrial ubiquitylation pathway drives a
program of OPTN/NDP52 recruitment and TBK1 activation to
promote mitophagy. Mol. Cell 2015, 60:7-20.
These papers describe the key autophagy adaptor proteins involved in
the downstream steps of mitophagy. Lazarou et al., also provide evi-
dence for PINK1-mediated Parkin-independent mitophagy.
23. Richter B, Sliter DA, Herhaus L, Stolz A, Wang C, Beli P,
Zaffagnini G, Wild P, Martens S, Wagner SA et al.:
Phosphorylation of OPTN by TBK1 enhances its binding to Ub
chains and promotes selective autophagy of damaged
mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2016, 113:4039-
4044.
24. Nguyen TN, Padman BS, Usher J, Oorschot V, Ramm G,
Lazarou M: Atg8 family LC3/GABARAP proteins are crucial for
autophagosome-lysosome fusion but not autophagosome
formation during PINK1/Parkin mitophagy and starvation. J.
Cell Biol. 2016, 215:857-874.
25. Tsuboyama K, Koyama-Honda I, Sakamaki Y, Koike M,
Morishita H, Mizushima N: The ATG conjugation systems are
important for degradation of the inner autophagosomal
membrane. Science 2016, 354:1036-1041.
26. Rojansky R, Cha MY, Chan DC: Elimination of paternal
mitochondria in mouse embryos occurs through autophagic
degradation dependent on PARKIN and MUL1. eLife 2016, 5.
27. Yamano K, Fogel AI, Wang C, van der Bliek AM, Youle RJ:
Mitochondrial Rab GAPs govern autophagosome biogenesis
during mitophagy. eLife 2014, 3:e01612.
28.

Lai YC, Kondapalli C, Lehneck R, Procter JB, Dill BD, Woodroof HI,
Gourlay R, Peggie M, Macartney TJ, Corti O et al.:
Phosphoproteomic screening identifies Rab GTPases as
novel downstream targets of PINK1. EMBO J. 2015, 34:2840-
2861.
Combining phosphoproteomic screening and biochemical analyses, this
study implicates several Rab proteins including Rab8A as downstream
targets of PINK1 following mitochondrial damage.
29. Randow F, Youle RJ: Self and nonself: how autophagy targets
mitochondria and bacteria. Cell Host Microbe 2014, 15:403-411.
30.

Pickrell AM, Huang CH, Kennedy SR, Ordureau A, Sideris DP,
Hoekstra JG, Harper JW, Youle RJ: Endogenous Parkin
preserves dopaminergic substantia nigral neurons following
mitochondrial DNA mutagenic stress. Neuron 2015, 87:371-
381.
This important proof-of-concept study demonstrates that genetic abla-
tion of Parkin results in age-dependent neurodegeneration under condi-
tions of constitutive mitochondrial stress by crossing Parkin-null mice
with the PolG mitochondrial mutator mouse model.
31. Dave KD, De Silva S, Sheth NP, Ramboz S, Beck MJ, Quang C,
Switzer RC 3rd, Ahmad SO, Sunkin SM, Walker D et al.:
Phenotypic characterization of recessive gene knockout rat
models of Parkinson’s disease. Neurobiol. Dis. 2014, 70:190-
203.
32. Villeneuve LM, Purnell PR, Boska MD, Fox HS: Early expression
of Parkinson’s disease-related mitochondrial abnormalities in
PINK1 knockout rats. Mol. Neurobiol. 2016, 53:171-186.
90 Cell regulation
Current Opinion in Cell Biology 2017, 45:83–91 www.sciencedirect.com
33. Fiesel FC, Ando M, Hudec R, Hill AR, Castanedes-Casey M,
Caulfield TR, Moussaud-Lamodiere EL, Stankowski JN, Bauer PO,
Lorenzo-Betancor O: (Patho-)physiological relevance of PINK1-
dependent ubiquitin phosphorylation. EMBO. Rep. 2015,
16:1114-1130.
34. Chung SY, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A,
Mosharov EV, Puspita L, Valiulahi P, Sulzer D, Milner TA et al.:
Parkin and PINK1 patient iPSC-derived midbrain dopamine
neurons exhibit mitochondrial dysfunction and alpha-
synuclein accumulation. Stem Cell Rep. 2016, 7:664-677.
35. Khaminets A, Behl C, Dikic I: Ubiquitin-dependent and
independent signals in selective autophagy. Trends Cell Biol.
2016, 26:6-16.
36. Herhaus L, Dikic I: Expanding the ubiquitin code through post-
translational modification. EMBO Rep. 2015, 16:1071-1083.
37. Swaney DL, Rodriguez-Mias RA, Villen J: Phosphorylation of
ubiquitin at Ser65 affects its polymerization, targets, and
proteome-wide turnover. EMBO Rep. 2015, 16:1131-1144.
38. Palikaras K, Lionaki E, Tavernarakis N: Coordination of
mitophagy and mitochondrial biogenesis during ageing in C.
elegans. Nature 2015, 521:525-528.
39. Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP,
MacCoss MJ, Pallanck LJ: The PINK1-Parkin pathway
promotes both mitophagy and selective respiratory chain
turnover in vivo. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:6400-
6405.
40. McWilliams TG, Ganley IG: Life in lights: tracking mitochondrial
delivery to lysosomes in vivo. Autophagy 2016, 12:2506-2507.
41.

McWilliams TG, Prescott AR, Allen GF, Tamjar J, Munson MJ,
Thomson C, Muqit MM, Ganley IG: mito-QC illuminates
mitophagy and mitochondrial architecture in vivo. J. Cell Biol.
2016, 214:333-345.
42.

Sun N, Yun J, Liu J, Malide D, Liu C, Rovira II, Holmstrom KM,
Fergusson MM, Yoo YH, Combs CA et al.: Measuring in vivo
mitophagy. Mol. Cell 2015, 60:685-696.
These two papers employ novel reporter mouse models to describe the
unique basal nature of mammalian mitophagy for the first time in
vivo. These technological advances herald powerful tools to uncover
the physiological roles of mitophagy.
43. Ashrafi G, Schlehe JS, LaVoie MJ, Schwarz TL: Mitophagy of
damaged mitochondria occurs locally in distal neuronal axons
and requires PINK1 and Parkin. J. Cell Biol. 2014, 206:655-670.
44.

Davis CH, Kim KY, Bushong EA, Mills EA, Boassa D, Shih T,
Kinebuchi M, Phan S, Zhou Y, Bihlmeyer NA et al.: Transcellular
degradation of axonal mitochondria. Proc. Natl. Acad. Sci. U. S.
A. 2014, 111:9633-9638.
Classically, mitochondrial delivery to the lysosome has been studied in
the context of intracellular degradation. This paper is the first to describe
axonal trans-mitophagy in vivo and provokes a reassessment of how
mitophagy proceeds in complex systems.
45. Davis CH, Marsh-Armstrong N: Discovery and implications of
transcellular mitophagy. Autophagy 2014, 10:2383-2384.
46. Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C, Ji X,
Lo EH: Transfer of mitochondria from astrocytes to neurons
after stroke. Nature 2016, 535:551-555.
47.

McLelland GL, Soubannier V, Chen CX, McBride HM, Fon EA:
Parkin and PINK1 function in a vesicular trafficking pathway
regulating mitochondrial quality control. EMBO J. 2014,
33:282-295.
This study implicates PINK1-Parkin signalling in the regulation of mito-
chondrial-derived vesicles (MDVs) following mitochondrial damage.
MDVs were noted to contain selective damaged mitochondrial cargos
that are targeted to the lysosome for destruction.
48. Sugiura A, McLelland GL, Fon EA, McBride HM: A new pathway
for mitochondrial quality control: mitochondrial-derived
vesicles. EMBO J. 2014, 33:2142-2156.
49. McLelland GL, Lee SA, McBride HM, Fon EA: Syntaxin-17
delivers PINK1/parkin-dependent mitochondrial vesicles to
the endolysosomal system. J. Cell Biol. 2016, 214:275-291.
50. Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A,
Rondeau C, Chemali M, Fazel A, Bergeron JJ, Trudeau LE,
Burelle Y et al.: Parkinson’s disease-related proteins PINK1 and
Parkin repress mitochondrial antigen presentation. Cell 2016,
166:314-327.
51. Roberts RF, Fon EA: Presenting mitochondrial antigens: PINK1,
Parkin and MDVs steal the show. Cell Res. 2016, 26:1180-1181.
52. Murley A, Nunnari J: The emerging network of mitochondria-
organelle contacts. Mol. Cell 2016, 61:648-653.
53. Sugiura A, Mattie S, Prudent J, McBride HM: Newly born
peroxisomes are a hybrid of mitochondrial and ER-derived
pre-peroxisomes. Nature 2017, 542:251-254.
54. Pao KC, Stanley M, Han C, Lai YC, Murphy P, Balk K, Wood NT,
Corti O, Corvol JC, Muqit MM et al.: Probes of ubiquitin E3
ligases enable systematic dissection of parkin activation. Nat.
Chem. Biol. 2016, 12:324-331.
55. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R,
Kaneko T: Single nigrostriatal dopaminergic neurons form
widely spread and highly dense axonal arborizations in the
neostriatum. J. Neurosci. 2009, 29:444-453.
56. Bolam JP, Pissadaki EK: Living on the edge with too many
mouths to feed: why dopamine neurons die. Mov. Disord. 2012,
27:1478-1483.
57. Crittenden JR, Tillberg PW, Riad MH, Shima Y, Gerfen CR, Curry J,
Housman DE, Nelson SB, Boyden ES, Graybiel AM: Striosome-
dendron bouquets highlight a unique striatonigral circuit
targeting dopamine-containing neurons. Proc. Natl. Acad. Sci.
U. S. A. 2016, 113:11318-11323.
58. Howe MW, Dombeck DA: Rapid signalling in distinct
dopaminergic axons during locomotion and reward. Nature
2016, 535:505-510.
PINK1 and Parkin: emerging themes in mitochondrial homeostasis McWilliams and Muqit 91
www.sciencedirect.com Current Opinion in Cell Biology 2017, 45:83–91
